Research Committee of Sleep Disorders in Covid-19 Patients, Vietnam Society of Sleep Medicine, 670000 Lam Dong Province, Vietnam.
Bio-Medical Research Center, Lam Dong Medical College, 670000 Lam Dong Province, Vietnam.
Discov Med. 2024 Apr;36(183):690-698. doi: 10.24976/Discov.Med.202436183.65.
Coronavirus disease 2019 (COVID-19) patients with sleep disorders may be at greater risk for respiratory exacerbation or death compared to those without. After being infected with COVID-19, patients have many symptoms related to sleep disorders, especially those with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. This study aimed to evaluate sleep disturbances in patients with severe SARS-CoV-2 infection who were treated in the Intensive Care Unit (ICU).
This cross-sectional study used the questionnaire provided by the Vietnam Sleep Disorder Study (ViSDiS) research, elaborated by the Vietnam Society of Sleep Medicine (VSSM). Seventy-seven COVID-19 patients were included.
There was a significant difference in sleep status before and after SARS-CoV-2 infection among participants. Up to 83% of them reported experiencing insomnia after illness, 60% reported having frequent nightmares, and more than half of participants reported nocturia ( < 0.0001). More than 81.8% of patients with severe SARS-CoV-2 infection were unsatisfied with their sleep quality during hospitalization After SARS-CoV-2 infection, only 2.6% of participants felt they had good quality sleep ( < 0.0001). The majority of patients suffered from fatigue after SARS-CoV-2 infection, including a lack of energy, feeling heaviness in their limbs, aggravation of pre-existing sleep disorders, idleness, constant fatigue throughout the day, and difficulty concentrating.
Sleep problems are highly prevalence among hospitalized patients with severe COVID-19 in the ICU. Healthcare providers should pay attention to sleep problems and their associated symptoms to initiate appropriate treatment to improve severe COVID-19 patients' health status and minimize the risk of death.
与没有睡眠障碍的 COVID-19 患者相比,患有睡眠障碍的 COVID-19 患者发生呼吸恶化或死亡的风险可能更高。感染 COVID-19 后,患者有许多与睡眠障碍相关的症状,尤其是那些患有严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的患者。本研究旨在评估在重症监护病房(ICU)接受治疗的严重 SARS-CoV-2 感染患者的睡眠障碍情况。
这是一项横断面研究,使用了由越南睡眠障碍研究(ViSDiS)研究提供的问卷,由越南睡眠医学会(VSSM)详细阐述。共纳入 77 例 COVID-19 患者。
参与者在 SARS-CoV-2 感染前后的睡眠状态存在显著差异。多达 83%的人报告患病后出现失眠,60%的人报告经常做噩梦,超过一半的人报告夜尿(<0.0001)。超过 81.8%的严重 SARS-CoV-2 感染患者对住院期间的睡眠质量不满意。感染 SARS-CoV-2 后,只有 2.6%的参与者认为自己的睡眠质量良好(<0.0001)。大多数患者在 SARS-CoV-2 感染后感到疲劳,包括精力不足、四肢沉重、原有睡眠障碍加重、懒散、整天疲劳和难以集中注意力。
在 ICU 住院的严重 COVID-19 患者中,睡眠问题非常普遍。医疗保健提供者应注意睡眠问题及其相关症状,以启动适当的治疗,改善严重 COVID-19 患者的健康状况,并最大限度地降低死亡风险。